Retatrutide Regulatory Status Retatrutide occupies a unique position because it is not yet FDA-approved: Not FDA-approved currently in Phase 3 clinical trials with Eli Lilly No prescription pathway in the US yet no Mounjaro/Wegovy equivalent for retatrutide Legal as research chemical sold in the US for in-vitro and animal research under research-use-only labeling Likely to receive FDA approval in coming years if clinical trial endpoints meet expectations WADA status currently not specifically listed, though peptide hormones generally fall under WADA categories Not DEA-scheduled no controlled substance status Unlike semaglutide and tirzepatide, retatrutide does not yet exist as a prescription drug
Muscle wasting can be an issue because people lose both fat and lean body mass as their weight goes down, Dr
For decades, women with PCOS were often handed birth control pills, told to lose weight, offered metformin, or sent home with the ever-helpful, Come back when you want to get pregnant. Bless it
Scientists are now investigating a wide range of metabolic peptide combinations designed to better understand how coordinated hormone signaling influences biological systems
In large clinical trials, most participants did not experience serious kidney problems
Kate Knibbs: They are definitely concerned, I'll say
